Lv22
200 积分 2026-10-05 加入
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
5天前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
7天前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
7天前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
7天前
已完结
High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity
1个月前
已完结
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
1个月前
已完结
Tertiary lymphoid structures in cancer
1个月前
已完结
Immunogenic cell stress and death
1个月前
已完结